These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34457058)

  • 1. Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein Survivin in a light-independent manner.
    Hasegawa T; Sugihara T; Hoshino Y; Tarumoto R; Matsuki Y; Kanda T; Takata T; Nagahara T; Matono T; Isomoto H
    Oncol Lett; 2021 Oct; 22(4):703. PubMed ID: 34457058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines".
    Sanna L; Piredda R; Marchesi I; Bordoni V; Forcales SV; Calvisi DF; Bagella L
    Chem Biol Interact; 2019 Oct; 312():108813. PubMed ID: 31494105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Yes-associated protein and transcriptional co-activator with PDZ-binding motif influences the behavior of LOVO human colon adenocarcinoma cells.
    Li Y; Li L; Zhu M; Ye L; Yang Q
    Exp Ther Med; 2017 Oct; 14(4):3831-3835. PubMed ID: 29042987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells.
    Lee Y; Finch-Edmondson M; Cognart H; Zhu B; Song H; Low BC; Sudol M
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway.
    Li Y; Yang S; Yang S
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
    Brouwer NJ; Konstantinou EK; Gragoudas ES; Marinkovic M; Luyten GPM; Kim IK; Jager MJ; Vavvas DG
    Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):3. PubMed ID: 33798262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers.
    Oku Y; Nishiya N; Shito T; Yamamoto R; Yamamoto Y; Oyama C; Uehara Y
    FEBS Open Bio; 2015; 5():542-9. PubMed ID: 26199863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
    Konishi T; Schuster RM; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
    Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
    Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
    Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP/TAZ regulates the expression of proteoglycan 4 and tenascin C in superficial-zone chondrocytes.
    Delve E; Co V; Regmi SC; Parreno J; Schmidt TA; Kandel RA
    Eur Cell Mater; 2020 Jan; 39():48-64. PubMed ID: 31917459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAZ and YAP are frequently activated oncoproteins in sarcomas.
    Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
    Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
    Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
    Brodowska K; Al-Moujahed A; Marmalidou A; Meyer Zu Horste M; Cichy J; Miller JW; Gragoudas E; Vavvas DG
    Exp Eye Res; 2014 Jul; 124():67-73. PubMed ID: 24837142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis.
    Wang S; Ma K; Chen L; Zhu H; Liang S; Liu M; Xu N
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27515420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.
    Lui JW; Xiao S; Ogomori K; Hammarstedt JE; Little EC; Lang D
    J Cancer; 2019; 10(1):1-10. PubMed ID: 30662519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic Acid Induces ECM Production via Activation of the Mechanosensitive YAP/TAZ Transcriptional Pathway in Trabecular Meshwork Cells.
    Ho LTY; Skiba N; Ullmer C; Rao PV
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1969-1984. PubMed ID: 29677358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation.
    Shrestha M; Ando T; Chea C; Sakamoto S; Nishisaka T; Ogawa I; Miyauchi M; Takata T
    Carcinogenesis; 2019 Oct; 40(10):1288-1297. PubMed ID: 31074490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.